Abstract
S. japonicum infection contributes to an increase in MDSCs, especially G-MDSCs, whose proliferation may inhibit the number of <sup>CD4+</sup> T cells in peripheral blood. Meanwhile, there is a close relationship between proliferation of G-MDSCs and liver fibrosis in S. japonicum-infected patients.
Introduction
Schistosomiasis remains a significant public health challenge, particularly in China where Schistosoma japonicum is prevalent. The chronic pathology of the disease, notably liver fibrosis, is primarily driven by the host's immune response to parasite eggs trapped in hepatic tissue. Myeloid-derived suppressor cells (MDSCs) are known immune regulators that expand during chronic infections to mitigate inflammation. However, their specific role in human schistosomiasis has remained poorly understood, with most existing data derived from murine models. This study aims to characterize MDSC subsets in human patients and evaluate their relationship with clinical outcomes, such as T-cell counts and liver health.
Methods
This retrospective case-control study involved 56 patients infected with S. japonicum and 21 healthy controls. Infected patients were further categorized into chronic (CSJ) and advanced (ASJ) stages based on clinical criteria including portal hypertension and liver fibrosis severity.
Key methodologies included:
- Flow Cytometry: Quantification of MDSC subsets (G-MDSCs and M-MDSCs) and lymphocyte populations (CD3+, CD4+, CD8+ T cells, B cells, and NK cells) from peripheral blood mononuclear cells (PBMCs).
- B-ultrasound Grading: Assessment of liver fibrosis severity using the Niamey Guide (Grades 0 to III).
- Statistical Analysis: Pearson correlation was employed to analyze the relationships between MDSC levels, T-cell counts, and fibrosis grades.
Results
The study revealed a massive expansion of granulocytic MDSCs (G-MDSCs) in infected patients. While healthy controls exhibited negligible levels (0.30% ± 0.36%), infected patients averaged 32.25% ± 18.76% ($p < 0.001$). Conversely, monocytic MDSCs (M-MDSCs) were found to decrease in infected individuals compared to controls.
A significant negative correlation was observed between the percentage of G-MDSCs and the absolute count of CD4+ T cells ($r = -0.279, p = 0.037$), suggesting that G-MDSC proliferation may inhibit the helper T-cell response. Furthermore, G-MDSC levels were positively correlated with liver fibrosis grading ($r = 0.356, p = 0.017$), with significantly higher levels in patients showing signs of fibrosis (Grade > 0). While MDSC levels were elevated across all infected patients, a trend toward higher levels in advanced cases compared to chronic cases was noted, though it did not always reach statistical significance.
Discussion
These findings highlight G-MDSCs as potential biomarkers for disease progression in schistosomiasis. Their expansion correlates with both weakened T-cell responses and increased liver damage. However, the study is limited by its sample size and the inability to definitively establish causation between G-MDSC proliferation and fibrosis. Additionally, functional assays are required to elucidate the exact molecular mechanisms by which these cells suppress T-cell activity. Future research should investigate whether therapeutic targeting of G-MDSCs could mitigate liver scarring in chronic schistosomiasis patients.
Summary updated